244 related articles for article (PubMed ID: 7842711)
1. HPMPC, a broad-spectrum topical antiviral agent, inhibits herpes simplex virus type 1 replication and promotes healing of dendritic keratitis in the New Zealand rabbit ocular model.
Gordon YJ; Romanowski EG; Araullo-Cruz T
Cornea; 1994 Nov; 13(6):516-20. PubMed ID: 7842711
[TBL] [Abstract][Full Text] [Related]
2. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
Romanowski EG; Bartels SP; Gordon YJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
[TBL] [Abstract][Full Text] [Related]
3. Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model.
Romanowski EG; Araullo-Cruz T; Gordon YJ
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):253-7. PubMed ID: 9019458
[TBL] [Abstract][Full Text] [Related]
4. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
Gordon YJ; Romanowski EG; Araullo-Cruz T
Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):4135-43. PubMed ID: 7960596
[TBL] [Abstract][Full Text] [Related]
5. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
Maudgal PC; De Clercq E
Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
De Clercq E
Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
[TBL] [Abstract][Full Text] [Related]
7. Cidofovir and experimental herpetic stromal disease.
Kaufman HE; Varnell ED; Thompson HW
Arch Ophthalmol; 1999 Jul; 117(7):925-8. PubMed ID: 10408458
[TBL] [Abstract][Full Text] [Related]
8. Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis.
Kaufman HE; Varnell ED; Thompson HW
Arch Ophthalmol; 1998 Jun; 116(6):777-80. PubMed ID: 9639447
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model.
Romanowski EG; Gordon YJ
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):460-3. PubMed ID: 10670476
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis.
Asbell PA; Epstein SP; Wallace JA; Epstein D; Stewart CC; Burger RM
Cornea; 1998 Sep; 17(5):550-7. PubMed ID: 9756451
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
12. Effects of diclofenac or ketorolac on the inhibitory activity of cidofovir in the Ad5/NZW rabbit model.
Romanowski EG; Gordon YJ
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):158-62. PubMed ID: 11133861
[TBL] [Abstract][Full Text] [Related]
13. Effect of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine on the replication and morphogenesis of herpes simplex virus type 1.
Chatterjee S; Burns P; Whitley RJ; Kern ER
Antiviral Res; 1992 Sep; 19(3):181-92. PubMed ID: 1332603
[TBL] [Abstract][Full Text] [Related]
14. The treatment of herpes simplex virus epithelial keratitis.
Wilhelmus KR
Trans Am Ophthalmol Soc; 2000; 98():505-32. PubMed ID: 11190039
[TBL] [Abstract][Full Text] [Related]
15. Timolol induces HSV-1 ocular shedding in the latently infected rabbit.
Hill JM; Shimomura Y; Dudley JB; Berman E; Haruta Y; Kwon BS; Maguire LJ
Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):585-90. PubMed ID: 3030959
[TBL] [Abstract][Full Text] [Related]
16. Trifluridine decreases ocular HSV-1 recovery, but not herpetic lesions after timolol iontophoresis.
Rootman DS; Hill JM; Haruta Y; Reidy JJ; Kaufman HE
Invest Ophthalmol Vis Sci; 1989 Apr; 30(4):678-83. PubMed ID: 2539342
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs.
Bravo FJ; Stanberry LR; Kier AB; Vogt PE; Kern ER
Antiviral Res; 1993 May; 21(1):59-72. PubMed ID: 8391249
[TBL] [Abstract][Full Text] [Related]
18. Effects of topical and subconjunctival cidofovir (HPMPC) in an animal model.
Banker AS; Bergeron-Lynn G; Keefe KS; De Clercq E; Taskintuna I; Freeman WR
Curr Eye Res; 1998 Jun; 17(6):560-6. PubMed ID: 9663845
[TBL] [Abstract][Full Text] [Related]
19. Human interferon alpha A or alpha D and trifluridine treatment for herpetic keratitis in rabbits.
Trousdale MD; Nesburn AB
Invest Ophthalmol Vis Sci; 1984 Apr; 25(4):480-3. PubMed ID: 6423563
[TBL] [Abstract][Full Text] [Related]
20. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
Aduma P; Connelly MC; Srinivas RV; Fridland A
Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
